Serum lipid changes during anticonvulsive treatment Serum lipids in epileptic children

dc.contributor.authorYilmaz, E
dc.contributor.authorDosan, Y
dc.contributor.authorGurgöze, MK
dc.contributor.authorGüngör, S
dc.date.accessioned2026-08-12T17:10:32Z
dc.date.issued2001
dc.departmentFırat Üniversitesi
dc.description.abstractSerum lipid profile changes were investigated in 53 children receiving phenobarbital (n = 14), carbamazepine (n = 21), and valproic acid (n 18) for their newly, diagnosed seizure disorder. The patients were,followed prospectively. Serum total cholesterol, high-density, lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride concentrations increased after 3 months of treatment with carbainazepine and remained high after one year Serum total cholesterol levels increased after 3 months of treatment with phenobarbital and remained high after one year Serum lipid concentrations did not change during valproic acid therapy. Serum lipid profiles should be carefully, monitored in children receiving enzyme inducing antiepileptic drugs.
dc.identifier.endpage220
dc.identifier.issn0300-9009
dc.identifier.issue4
dc.identifier.orcid0000-0003-3875-6770
dc.identifier.pmid11851028
dc.identifier.scopus2-s2.0-0035704409
dc.identifier.scopusqualityQ2
dc.identifier.startpage217
dc.identifier.urihttps://hdl.handle.net/11508/50761
dc.identifier.volume101
dc.identifier.wosWOS:000174057900004
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherActa Medica Belgica
dc.relation.ispartofActa Neurologica Belgica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectepilepsy
dc.subjectanticonvulsants
dc.subjecthyperlipidemia
dc.subjectatherosclerosis
dc.titleSerum lipid changes during anticonvulsive treatment Serum lipids in epileptic children
dc.typeArticle

Dosyalar